Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Faecal Microbiota Transplant(FMT) Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Oral
1.2.3 Enema
1.3 Market by Application
1.3.1 Global Faecal Microbiota Transplant(FMT) Therapy Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Clostridioides Difficile Infection(CDI)
1.3.3 Digestive System Disease
1.3.4 Nervous System Disease
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Faecal Microbiota Transplant(FMT) Therapy Market Perspective (2018-2033)
2.2 Faecal Microbiota Transplant(FMT) Therapy Growth Trends by Region
2.2.1 Global Faecal Microbiota Transplant(FMT) Therapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Faecal Microbiota Transplant(FMT) Therapy Historic Market Size by Region (2018-2023)
2.2.3 Faecal Microbiota Transplant(FMT) Therapy Forecasted Market Size by Region (2024-2033)
2.3 Faecal Microbiota Transplant(FMT) Therapy Market Dynamics
2.3.1 Faecal Microbiota Transplant(FMT) Therapy Industry Trends
2.3.2 Faecal Microbiota Transplant(FMT) Therapy Market Drivers
2.3.3 Faecal Microbiota Transplant(FMT) Therapy Market Challenges
2.3.4 Faecal Microbiota Transplant(FMT) Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Faecal Microbiota Transplant(FMT) Therapy Players by Revenue
3.1.1 Global Top Faecal Microbiota Transplant(FMT) Therapy Players by Revenue (2018-2023)
3.1.2 Global Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Faecal Microbiota Transplant(FMT) Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Faecal Microbiota Transplant(FMT) Therapy Revenue
3.4 Global Faecal Microbiota Transplant(FMT) Therapy Market Concentration Ratio
3.4.1 Global Faecal Microbiota Transplant(FMT) Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Faecal Microbiota Transplant(FMT) Therapy Revenue in 2022
3.5 Faecal Microbiota Transplant(FMT) Therapy Key Players Head office and Area Served
3.6 Key Players Faecal Microbiota Transplant(FMT) Therapy Product Solution and Service
3.7 Date of Enter into Faecal Microbiota Transplant(FMT) Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Faecal Microbiota Transplant(FMT) Therapy Breakdown Data by Type
4.1 Global Faecal Microbiota Transplant(FMT) Therapy Historic Market Size by Type (2018-2023)
4.2 Global Faecal Microbiota Transplant(FMT) Therapy Forecasted Market Size by Type (2024-2033)
5 Faecal Microbiota Transplant(FMT) Therapy Breakdown Data by Application
5.1 Global Faecal Microbiota Transplant(FMT) Therapy Historic Market Size by Application (2018-2023)
5.2 Global Faecal Microbiota Transplant(FMT) Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Faecal Microbiota Transplant(FMT) Therapy Market Size (2018-2033)
6.2 North America Faecal Microbiota Transplant(FMT) Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2018-2023)
6.4 North America Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Faecal Microbiota Transplant(FMT) Therapy Market Size (2018-2033)
7.2 Europe Faecal Microbiota Transplant(FMT) Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2018-2023)
7.4 Europe Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Market Size (2018-2033)
8.2 Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Faecal Microbiota Transplant(FMT) Therapy Market Size (2018-2033)
9.2 Latin America Faecal Microbiota Transplant(FMT) Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2018-2023)
9.4 Latin America Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Market Size (2018-2033)
10.2 Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Enterome Bioscience
11.1.1 Enterome Bioscience Company Detail
11.1.2 Enterome Bioscience Business Overview
11.1.3 Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Introduction
11.1.4 Enterome Bioscience Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2018-2023)
11.1.5 Enterome Bioscience Recent Development
11.2 Rebiotix
11.2.1 Rebiotix Company Detail
11.2.2 Rebiotix Business Overview
11.2.3 Rebiotix Faecal Microbiota Transplant(FMT) Therapy Introduction
11.2.4 Rebiotix Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2018-2023)
11.2.5 Rebiotix Recent Development
11.3 Ritter Pharmaceuticals
11.3.1 Ritter Pharmaceuticals Company Detail
11.3.2 Ritter Pharmaceuticals Business Overview
11.3.3 Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Introduction
11.3.4 Ritter Pharmaceuticals Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2018-2023)
11.3.5 Ritter Pharmaceuticals Recent Development
11.4 Finch Therapeutics
11.4.1 Finch Therapeutics Company Detail
11.4.2 Finch Therapeutics Business Overview
11.4.3 Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Introduction
11.4.4 Finch Therapeutics Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2018-2023)
11.4.5 Finch Therapeutics Recent Development
11.5 Crestovo
11.5.1 Crestovo Company Detail
11.5.2 Crestovo Business Overview
11.5.3 Crestovo Faecal Microbiota Transplant(FMT) Therapy Introduction
11.5.4 Crestovo Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2018-2023)
11.5.5 Crestovo Recent Development
11.6 Maat Pharma
11.6.1 Maat Pharma Company Detail
11.6.2 Maat Pharma Business Overview
11.6.3 Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Introduction
11.6.4 Maat Pharma Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2018-2023)
11.6.5 Maat Pharma Recent Development
11.7 Seres Therapeutics
11.7.1 Seres Therapeutics Company Detail
11.7.2 Seres Therapeutics Business Overview
11.7.3 Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Introduction
11.7.4 Seres Therapeutics Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2018-2023)
11.7.5 Seres Therapeutics Recent Development
11.8 Second Genome
11.8.1 Second Genome Company Detail
11.8.2 Second Genome Business Overview
11.8.3 Second Genome Faecal Microbiota Transplant(FMT) Therapy Introduction
11.8.4 Second Genome Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2018-2023)
11.8.5 Second Genome Recent Development
11.9 OpenBiome
11.9.1 OpenBiome Company Detail
11.9.2 OpenBiome Business Overview
11.9.3 OpenBiome Faecal Microbiota Transplant(FMT) Therapy Introduction
11.9.4 OpenBiome Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2018-2023)
11.9.5 OpenBiome Recent Development
11.10 MicroBiome Therapeutics
11.10.1 MicroBiome Therapeutics Company Detail
11.10.2 MicroBiome Therapeutics Business Overview
11.10.3 MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Introduction
11.10.4 MicroBiome Therapeutics Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2018-2023)
11.10.5 MicroBiome Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Faecal Microbiota Transplant(FMT) Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Oral
Table 3. Key Players of Enema
Table 4. Global Faecal Microbiota Transplant(FMT) Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Faecal Microbiota Transplant(FMT) Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Faecal Microbiota Transplant(FMT) Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Faecal Microbiota Transplant(FMT) Therapy Market Share by Region (2018-2023)
Table 8. Global Faecal Microbiota Transplant(FMT) Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Faecal Microbiota Transplant(FMT) Therapy Market Share by Region (2024-2033)
Table 10. Faecal Microbiota Transplant(FMT) Therapy Market Trends
Table 11. Faecal Microbiota Transplant(FMT) Therapy Market Drivers
Table 12. Faecal Microbiota Transplant(FMT) Therapy Market Challenges
Table 13. Faecal Microbiota Transplant(FMT) Therapy Market Restraints
Table 14. Global Faecal Microbiota Transplant(FMT) Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Faecal Microbiota Transplant(FMT) Therapy Market Share by Players (2018-2023)
Table 16. Global Top Faecal Microbiota Transplant(FMT) Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Faecal Microbiota Transplant(FMT) Therapy as of 2022)
Table 17. Ranking of Global Top Faecal Microbiota Transplant(FMT) Therapy Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Faecal Microbiota Transplant(FMT) Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Faecal Microbiota Transplant(FMT) Therapy Product Solution and Service
Table 21. Date of Enter into Faecal Microbiota Transplant(FMT) Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Faecal Microbiota Transplant(FMT) Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share by Type (2018-2023)
Table 25. Global Faecal Microbiota Transplant(FMT) Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share by Type (2024-2033)
Table 27. Global Faecal Microbiota Transplant(FMT) Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share by Application (2018-2023)
Table 29. Global Faecal Microbiota Transplant(FMT) Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share by Application (2024-2033)
Table 31. North America Faecal Microbiota Transplant(FMT) Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Faecal Microbiota Transplant(FMT) Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Faecal Microbiota Transplant(FMT) Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 46. Enterome Bioscience Company Detail
Table 47. Enterome Bioscience Business Overview
Table 48. Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Product
Table 49. Enterome Bioscience Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2018-2023) & (US$ Million)
Table 50. Enterome Bioscience Recent Development
Table 51. Rebiotix Company Detail
Table 52. Rebiotix Business Overview
Table 53. Rebiotix Faecal Microbiota Transplant(FMT) Therapy Product
Table 54. Rebiotix Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2018-2023) & (US$ Million)
Table 55. Rebiotix Recent Development
Table 56. Ritter Pharmaceuticals Company Detail
Table 57. Ritter Pharmaceuticals Business Overview
Table 58. Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Product
Table 59. Ritter Pharmaceuticals Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2018-2023) & (US$ Million)
Table 60. Ritter Pharmaceuticals Recent Development
Table 61. Finch Therapeutics Company Detail
Table 62. Finch Therapeutics Business Overview
Table 63. Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product
Table 64. Finch Therapeutics Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2018-2023) & (US$ Million)
Table 65. Finch Therapeutics Recent Development
Table 66. Crestovo Company Detail
Table 67. Crestovo Business Overview
Table 68. Crestovo Faecal Microbiota Transplant(FMT) Therapy Product
Table 69. Crestovo Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2018-2023) & (US$ Million)
Table 70. Crestovo Recent Development
Table 71. Maat Pharma Company Detail
Table 72. Maat Pharma Business Overview
Table 73. Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Product
Table 74. Maat Pharma Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2018-2023) & (US$ Million)
Table 75. Maat Pharma Recent Development
Table 76. Seres Therapeutics Company Detail
Table 77. Seres Therapeutics Business Overview
Table 78. Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product
Table 79. Seres Therapeutics Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2018-2023) & (US$ Million)
Table 80. Seres Therapeutics Recent Development
Table 81. Second Genome Company Detail
Table 82. Second Genome Business Overview
Table 83. Second Genome Faecal Microbiota Transplant(FMT) Therapy Product
Table 84. Second Genome Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2018-2023) & (US$ Million)
Table 85. Second Genome Recent Development
Table 86. OpenBiome Company Detail
Table 87. OpenBiome Business Overview
Table 88. OpenBiome Faecal Microbiota Transplant(FMT) Therapy Product
Table 89. OpenBiome Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2018-2023) & (US$ Million)
Table 90. OpenBiome Recent Development
Table 91. MicroBiome Therapeutics Company Detail
Table 92. MicroBiome Therapeutics Business Overview
Table 93. MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product
Table 94. MicroBiome Therapeutics Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2018-2023) & (US$ Million)
Table 95. MicroBiome Therapeutics Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Faecal Microbiota Transplant(FMT) Therapy Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Faecal Microbiota Transplant(FMT) Therapy Market Share by Type: 2022 VS 2033
Figure 3. Oral Features
Figure 4. Enema Features
Figure 5. Global Faecal Microbiota Transplant(FMT) Therapy Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Faecal Microbiota Transplant(FMT) Therapy Market Share by Application: 2022 VS 2033
Figure 7. Clostridioides Difficile Infection(CDI) Case Studies
Figure 8. Digestive System Disease Case Studies
Figure 9. Nervous System Disease Case Studies
Figure 10. Others Case Studies
Figure 11. Faecal Microbiota Transplant(FMT) Therapy Report Years Considered
Figure 12. Global Faecal Microbiota Transplant(FMT) Therapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Faecal Microbiota Transplant(FMT) Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Faecal Microbiota Transplant(FMT) Therapy Market Share by Region: 2022 VS 2033
Figure 15. Global Faecal Microbiota Transplant(FMT) Therapy Market Share by Players in 2022
Figure 16. Global Top Faecal Microbiota Transplant(FMT) Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Faecal Microbiota Transplant(FMT) Therapy as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Faecal Microbiota Transplant(FMT) Therapy Revenue in 2022
Figure 18. North America Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Faecal Microbiota Transplant(FMT) Therapy Market Share by Country (2018-2033)
Figure 20. United States Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Faecal Microbiota Transplant(FMT) Therapy Market Share by Country (2018-2033)
Figure 24. Germany Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Market Share by Region (2018-2033)
Figure 32. China Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Faecal Microbiota Transplant(FMT) Therapy Market Share by Country (2018-2033)
Figure 40. Mexico Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Market Share by Country (2018-2033)
Figure 44. Turkey Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Enterome Bioscience Revenue Growth Rate in Faecal Microbiota Transplant(FMT) Therapy Business (2018-2023)
Figure 47. Rebiotix Revenue Growth Rate in Faecal Microbiota Transplant(FMT) Therapy Business (2018-2023)
Figure 48. Ritter Pharmaceuticals Revenue Growth Rate in Faecal Microbiota Transplant(FMT) Therapy Business (2018-2023)
Figure 49. Finch Therapeutics Revenue Growth Rate in Faecal Microbiota Transplant(FMT) Therapy Business (2018-2023)
Figure 50. Crestovo Revenue Growth Rate in Faecal Microbiota Transplant(FMT) Therapy Business (2018-2023)
Figure 51. Maat Pharma Revenue Growth Rate in Faecal Microbiota Transplant(FMT) Therapy Business (2018-2023)
Figure 52. Seres Therapeutics Revenue Growth Rate in Faecal Microbiota Transplant(FMT) Therapy Business (2018-2023)
Figure 53. Second Genome Revenue Growth Rate in Faecal Microbiota Transplant(FMT) Therapy Business (2018-2023)
Figure 54. OpenBiome Revenue Growth Rate in Faecal Microbiota Transplant(FMT) Therapy Business (2018-2023)
Figure 55. MicroBiome Therapeutics Revenue Growth Rate in Faecal Microbiota Transplant(FMT) Therapy Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed